Atara Biotherapeutics
ATRA
$0.69
Share price
-2.35%
Change (1 day)
-66.99%
Change (1 year)
Categories
Atara Biotherapeutics (ATRA) - Total assets
Total assets on the balance sheet as of December 2023 : $0.16 B
According to Atara Biotherapeutics's latest financial reports the company's total assets are $0.16 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Atara Biotherapeutics - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.37 B | -19.59% |
| 2021-12-31 | $0.46 B | -20.4% |
| 2020-12-31 | $0.58 B | 71.49% |
| 2019-12-31 | $0.34 B | -12.48% |
| 2018-12-31 | $0.39 B | 79.93% |
| 2017-12-31 | $0.21 B | -17.48% |
| 2016-12-31 | $0.26 B | -18.79% |
| 2015-12-31 | $0.32 B | 206.23% |
| 2014-12-31 | $0.10 B | 104.76% |
| 2013-12-31 | $51.82 M | 1108.11% |
| 2012-12-31 | $4.29 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | $0.82 B | 396.73% | 🇺🇸 USA |
 Agenus
AGEN | $0.31 B | 89.67% | 🇺🇸 USA |
 Affimed
AFMD | $0.10 B | -35.10% | 🇩🇪 Germany |